Dr. Anitha Vijayan, MD
Nephrology (Kidney) (Nephrology Physician)
5169 S Cottonwood St Ste 320
Murray, UT 84107
Who else practices at this address →
Salt Lake County includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 61
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
UT license 13327659-1205 · MO license 111039
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Intermountain Medical Center Murray, UT
- St. George Regional Hospital St George, UT
- Lds Hospital Salt Lake City, UT
Medical groups
- Ihc Health Services Inc (3,960 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 61
- Services billed
- 173
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 157 | 67 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 124 | 64 |
| Hemodialysis procedure with physician evaluation | 97 | 55 |
| Dialysis procedure including 1 evaluation | 62 | 21 |
| Established patient office or other outpatient visit, 30-39 minutes | 55 | 40 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 44 | 21 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 21 | 21 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 17 | 17 |
| Established patient office or other outpatient visit, 20-29 minutes | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Amlodipine Besylate Other prescribers in Murray, UT | 19 |
| Chlorthalidone Other prescribers in Murray, UT | 16 |
| Pantoprazole Sodium Other prescribers in Murray, UT | 14 |
| Allopurinol Other prescribers in Murray, UT | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 8 payments worth $5,561 in total to this clinician.
| Fresenius USA Marketing, Inc. | $5,494 |
|---|---|
| Nxstage Medical, Inc. | $35.00 |
| Travere Therapeutics, Inc. | $31.61 |
| Consulting Fee | $4,025 |
|---|---|
| Travel and Lodging | $1,036 |
| Food and Beverage | $500 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. Mar 26, 2025 | Consulting Fee NXSTAGE SYSTEM ONE · Nephrology | $4,025 |
| Fresenius USA Marketing, Inc. Mar 26, 2025 | Travel and Lodging NXSTAGE SYSTEM ONE · Nephrology · travel to Chicago, IL · in-kind | $717 |
| Fresenius USA Marketing, Inc. Mar 26, 2025 | Travel and Lodging NXSTAGE SYSTEM ONE · Nephrology · travel to Chicago, IL · in-kind | $245 |
| Fresenius USA Marketing, Inc. Mar 26, 2025 | Travel and Lodging NXSTAGE SYSTEM ONE · Nephrology · travel to Chicago, IL · in-kind | $64.80 |
| Fresenius USA Marketing, Inc. Mar 26, 2025 | Travel and Lodging NXSTAGE SYSTEM ONE · Nephrology · travel to Chicago, IL · in-kind | $8.75 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $259,334 in research payments for these studies, mostly to the institutions running them.
- SAfety of Regional Citrate Anticoagulation (SARCA Study)
Fresenius USA Marketing, Inc. · Completed · NCT05339139
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.